Giant coronary aneurysms in a young adult patient with Kawasaki disease

Puerto Rico Health Sciences Journal

Volumn 27, Issue 4, 2008, Pages 382-386

  Canino Rodríguez, Alexis ^a   Cox, Rafael A ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Coronary revascularization criteria; Giant coronary aneurysms; Kawasaki disease; Therapy

Indexed keywords

ADULT; CASE REPORT; CORONARY ARTERY ANEURYSM; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOLOGY; REVIEW;

CORONARY ANEURYSM; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; YOUNG ADULT;

EID: 61549097868     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997;6:181-185.
2. L eung DYM, Meissner HC, Schlievert PM. The etiology and pathogenesis of Kawasaki disease: how close are we to an answer? Curr Opin Infect Dis 1997;10:226-232.
3. Barron KS. Kawasaki disease: Etiology, pathogenesis and treatment. Cleve Clin J Med 2002;69(Suppl II):69-78.
4. E berhard BA, Anderson U, Laxer RM, Rose V, Silverman ED. Evaluation of cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995;14:199-203.
5. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor and interferon-gamma in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 1990;56:29-36.
6. Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatrics International 2005;47:232-234.
7. F ulton DR, Newburger JW. Long-term sequelae of Kawasaki disease, Curr Rheumatol Rep 2000;2:324-329.
8. Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 1981;47:323-330.
9. Akagi T, Kato H, Inoue O, Sato N, Imamura K. Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J 1990;120:366-372.
10. Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev 1988;9:209-217.
11. Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986;108:388-392.
12. Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S.Sensitivity, specificity and predictive value of two-dimensional ehocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1986;7:355-360.
13. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J CardioI 1982;49:1758-1766.
14. Suzuki A, Kamiya T, Ono Y, Kohata T, Kimura K, Takamiya M. Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective arteriography in 200 patients. Heart Vessels 1987;3:159-165.
15. I emura M, Ishii M, Sugimura T, et al. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000;83:307-311.
16. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-1639.
17. De Rosa G, Pardeo M, igante D. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci 2007;11:301-308.
18. Newburger J, Takahashi M, Gerber M, Gewitz M, Tani L, Burns J. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Circulation 2004;110:2747-2771.
19. Kitamura S. The role of coronary bypass operation on children with Kawasaki disease. Coron Artery Dis 2002;13:437-447.
20. Tsuda E, Kitamura S, Kimura K, et al. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. Am Heart J 2007;153:995-1000.
21. Tsuda E, Kitamura S. National Survey of Coronary Artery Bypass Grafting for Coronary Stenosis Caused by Kawasaki Disease in Japan. Circulation 2004;110:II-61-66.
22. Checchia PA, Pahl E, Shaddy RE, Schulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics 1997;100:695-699.
23. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow up study of 594 patients. Circulation 1996;94:1379-1385.
24. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991;84:625-631.
25. Aggarwala G, Iyengar N, Burke SJ, et al. Kawasaki disease: role of coronary CT angiography. Int J Cardiovasc Imaging 2006;22: 803-805.
26. Greil G, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002;105:908-911.
27. 28. Silva E, Anna AE, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, et al. Cardiovascular risk factors after Kawasaki disease:A case-control study. J Pediatr 2001;138:400-405.
28. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 2004;43:120-124.